世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033723

幹細胞技術と応用市場レポート2022-2032

Visiongain

Stem Cell Technologies and Applications Market Report 2022-2032

発刊日 2022/12/01

言語英語

体裁PDF/355ページ

ライセンス/価格355ページ

0000033723

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

種類別予測(同種幹細胞療法、自家幹細胞療法)、細胞源別(脂肪組織由来MSC、骨髄由来MSC、胎盤/臍帯由来MSC)、製品別(成体幹細胞、ヒト胚性幹細胞)、iPS細胞、非常に小さい胚様幹細胞)、技術別 (細胞取得、細胞生産、凍結保存、拡大およびサブカルチャー、その他)、用途別 (がん、心血管疾患、神経疾患、炎症性および自己免疫疾患、筋骨格疾患、その他) 、地域&主要国市場分析、加えて、主要企業の分析 およびCOVID-19 の影響と回復パターンの分析

新しい収益源を求めて、業界とその根底にあるダイナミクスについて理解を深めたいと考えている大手企業にとって、このレポートは非常に貴重な資料です。さまざまな業種に進出したり、新たな地域で既存の事業を拡大したい企業を支援します。

幹細胞臨床試験の増加

近年、幹細胞研究とこれらの有望な細胞の臨床使用の両方が大幅に拡大しています。国立衛生研究所 (NIH) のデータベースは、合計 374 件の登録された臨床試験を報告しましたが、その不明な状態は考慮されていませんでした。2011年以降、臨床試験の総数は3倍に拡大しています。幹細胞を用いた臨床試験は、近年の発展分野の進路を変えました。多くのチームが骨髄および臍帯血幹細胞の役割を開発し、免疫および血液疾患における最先端の用途に拡大し続けている一方で、他の多くのチームは骨髄および臍帯血に見られるさまざまな幹細胞タイプの用途を拡大しようとしています。血液、特に間葉系幹細胞は、自分の系統の細胞を置き換えることによって解決できるもの以外のものも使用します。他の成体幹細胞タイプ、特に脳幹細胞は、研究チームによって、系統内細胞置換または細胞外因子のいずれかがプラスの影響を与える可能性がある疾患を治療するために、より頻繁に使用されています。MSC 試験の大部分は同種異系細胞を使用したものであり、これらの試験は世界中で実施されており、米国、ヨーロッパ、中国で最大の活動が見られます。しかし、臨床試験が増加し、これらの試験を実施するために多額の投資が行われているにもかかわらず、これらの試験の商業化は遅く、この業界のすべての利害関係者にとっては懸念事項です。

レポート詳細

目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Stem Cell Technologies and Applications Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary
2.1 Geographical Snapshot: Global Stem Cell Technologies and Applications Market
2.2 Type Segment: Market Attractiveness Index
2.3 Cell Source Segment: Market Attractiveness Index
2.4 Product Segment: Market Attractiveness Index
2.5 Technology Segment: Market Attractiveness Index
2.6 Application Segment: Market Attractiveness Index

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.3 Supply Chain
3.4 Value Chain
3.5 COVID-19 Impact Analysis
3.5.1 Risks of COVID-19 for those Undergoing Stem Cell Transplants
3.6 Porter’s Five Forces Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Competitive Rivalry
3.6.4 Threat from Substitutes
3.6.5 Threat of New Entrants
3.7 PESTLE Analysis
3.7.1 Political Factors
3.7.2 Economic Factors
3.7.3 Social Factors
3.7.4 Technological Factors

4 Global Stem Cell Technologies and Applications Market Analysis by Type
4.1 Key Findings
4.2 Type Segment Growth Prospects
4.3 Type Segment: Market Attractiveness Index
4.4 Global Stem Cell Technologies and Applications Market Share by Type, 2022 & 2032
4.5 Global Stem Cell Technologies and Applications Market by Type
4.6 Allogenic Segment Market
4.6.1 Growing Prevalence of Cancer and Cardiovascular Diseases
4.6.2 Global Allogeneic Stem Cell Therapy Market by Type
4.6.3 Global Allogeneic Stem Cell Therapy Market by Region
4.7 Autologous Segment Market
4.7.1 Rising Frequency of Cancer
4.7.2 Global Autologous Stem Cell Therapy Market Forecast
4.7.3 Global Autologous Stem Cell Therapy Market by Region

5 Global Stem Cell Technologies and Applications Market Analysis by Cell Source
5.1 Key Findings
5.2 Cell Source Segment Growth Prospects
5.3 Cell Source Segment: Market Attractiveness Index
5.4 Global Stem Cell Technologies and Applications Market Share by Cell Source, 2022 & 2032
5.5 Global Stem Cell Technologies & Applications Market by Cell Source
5.6 Adipose Tissue- derived MSCs Segment Market Forecast
5.6.1 Source and Implication
5.6.2 Clinical Applications for Tissue Repair
5.6.3 Global Adipose Tissue-Derived MSCs Market Forecast
5.6.4 Global Adipose tissue-derived MSCs Market by Region
5.7 Bone Marrow- derived MSCs Segment Market Forecast
5.7.1 Bone Marrow Concept
5.7.2 Emerging Technology
5.7.3 Global Bone marrow-derived MSCs Market Forecast
5.7.4 Global Bone Marrow-Derived MSCs Market by Region
5.8 Placental/ Umbilical Cord- Derived MSCs Segment Market Forecast
5.8.1 Placental/ Umbilical Cord- Derived MSCs
5.8.2 Therapeutic Potential
5.8.3 Global Placental/Umbilical Cord-Derived MSCs Market Forecast
5.8.4 Global Placental/Umbilical Cord-Derived MSCs Market by Region

6 Global Stem Cell Technologies and Applications Market Analysis by Product
6.1 Key Findings
6.2 Product Segment Growth Prospects
6.3 Product Segment: Market Attractiveness Index
6.4 Global Stem Cell Technologies and Applications Market Share by Product, 2022 & 2032
6.5 Global Stem Cell Technologies & Applications Market by Product
6.6 Adult Stem Cells Segment Market Forecast
6.6.1 Rising Application Areas
6.6.2 Global Adult Stem Cells Market Forecast
6.6.3 Global Adult Stem Cells Market by Region
6.7 Human Embryonic Stem Cells Segment Market Forecast, 2021-2031
6.7.1 Increasing Research and Development Activities
6.7.2 Global Human Embryonic Stem Cells Market Forecast
6.7.3 Global Human Embryonic Stem Cells Market by Region
6.8 Induced Pluripotent Stem Cells Segment Market Forecast, 2021-2031
6.8.1 Favourable Government Support
6.8.2 Global Induced Pluripotent Stem Cells Market Forecast
6.8.3 Global Induced Pluripotent Stem Cells Market by Region
6.9 Very Small Embryonic Like Stem Cells
6.9.1 Global Very Small Embryonic Like Stem Cells Market Forecast
6.9.2 Global Very Small Embryonic Like Stem Cells Market by Region

7 Global Stem Cell Technologies and Applications Market Analysis by Technology
7.1 Key Findings
7.2 Technology Segment Growth Prospects
7.3 Technology Segment: Market Attractiveness Index
7.4 Global Stem Cell Technologies and Applications Market Share by Technology, 2022 & 2032
7.5 Global Stem Cell Technologies & Applications Market by Technology
7.6 Cell Acquisition Segment Market Forecast
7.6.1 Global Cell Acquisition Market Forecast
7.6.2 Global Cell Acquisition Market by Region
7.7 Cell Production Segment Market Forecast
7.7.1 Increasing Research and Development by Companies for the Development of Stem Cell Products
7.7.2 Global Cell Production Market Forecast
7.7.3 Global Cell Production Market by Region
7.8 Cryopreservation Segment Market Forecast
7.8.1 Surge in Research and Medical Applications
7.8.2 Global Cryopreservation Market Forecast
7.8.3 Global Cryopreservation Market by Region
7.9 Expansion & Sub-Culture Segment Market Forecast
7.9.1 Sub-culture
7.9.2 Rising Incidence of Chronic Diseases
7.9.3 Global Expansion & Sub-Culture Market Forecast
7.9.4 Global Expansion & Sub-Culture Market Forecast by Region
7.10 Other Technology Market Forecast
7.10.1 Global Other Technology Market Forecast
7.10.2 Global Other Technology Market by Region

8 Global Stem Cell Technologies and Applications Market Analysis by Application
8.1 Key Findings
8.2 Application Segment Growth Prospects
8.3 Application Segment: Market Attractiveness Index
8.4 Global Stem Cell Technologies and Applications Market Share by Application, 2022 & 2032
8.4.1 Global Stem Cell Technologies & Applications Market by Application
8.5 Therapeutic Application Segment Market Forecast
8.5.1 Rising Prevalence of Cardiovascular Diseases
8.5.2 Utilizing Stem Cell Technologies Therapeutically to Treat Parkinson's Illness
8.5.1 Cancer Segment Market Forecast
8.5.2 Cardiovascular Segment Market Forecast
8.5.3 CNS Segment Market Forecast
8.5.4 Inflammatory & Autoimmune Diseases Segment Market Forecast
8.5.5 Musculoskeletal Disorders Segment Market Forecast
8.6 Non-Therapeutic Application Segment Market Forecast
8.6.1 Rising Awareness of Stem Cell therapies propels the Growth of Stem Cell Banking
8.6.2 Global Other Applications Market Forecast
8.6.3 Global Other Applications Market by Region

9 Global Stem Cell Technologies and Applications Market Analysis by Region
9.1 Key Findings
9.2 Overview
9.3 Global Stem Cell Technologies & Applications, By Region Market Attractiveness Index
9.4 Global Stem Cell Technologies and Applications Market Share by Application, 2022 & 2032
9.5 Global Stem Cell Technologies & Applications Market Forecast
9.5.1 Global Stem Cell Technologies & Applications Market Forecast
9.5.2 Global Stem Cell Technologies & Applications Market Forecast (Post-CoViD-19)
9.6 Global Stem Cell Technologies & Applications Market by Region
9.6.1 Global Stem Cell Technologies & Applications Market by Region Forecast
9.6.2 Global Stem Cell Technologies & Applications Market by Region Forecast (Post-CoViD-19)

10 North America Stem Cell Technologies and Applications Market Analysis
10.1 Key Findings
10.2 North America Stem Cell Technologies and Applications Market Attractiveness Index
10.3 Rising Prevalence of Cancer
10.4 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast
10.5 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
10.6 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
10.7 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
10.8 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
10.9 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
10.10 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
10.11 U.S. Stem Cell Technologies & Application Market Forecast
10.11.1 Growing Biotechnology Sector and Increasing Stem Cell Research
10.12 Canada Stem Cell Technologies & Application Market Forecast
10.12.1 Growing Biotechnology Sector and Increasing Stem Cell Research

11 Europe Stem Cell Technologies and Applications Market Analysis
11.1 Key Findings
11.2 Europe Stem Cell Technologies and Applications Market Attractiveness Index
11.3 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
11.4 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
11.5 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
11.6 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
11.7 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
11.8 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
11.9 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
11.10 Germany Stem Cell Technologies & Application Market Forecast
11.10.1 Rising Technological Advancements Supports the Growth of the Market
11.11 U.K. Stem Cell Technologies & Application Market Forecast
11.11.1 Increasing Research and Development Activities
11.12 France Stem Cell Technologies & Application Market Forecast, 2021-2031
11.12.1 Introduction of New and Innovative Stem Cell Products for Rare Diseases
11.13 Italy Stem Cell Technologies & Application Market Forecast
11.13.1 Increasing Clinical Trials
11.14 Spain Stem Cell Technologies & Application Market Forecast
11.14.1 Rising Research and Development Activities
11.15 Rest of Europe Stem Cell Technologies & Application Market Forecast, 2021-2031
11.15.1 Rising Need for New and Innovative Technologies
11.15.2 Russia Stem Cell Technologies & Application Market Forecast

12 Asia-Pacific Stem Cell Technologies and Applications Market Analysis
12.1 Key Findings
12.2 Asia-Pacific Stem Cell Technologies and Applications Market Attractiveness Index
12.3 Rise in Aging Population
12.4 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
12.5 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
12.7 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
12.8 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
12.9 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
12.10 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
12.11 Japan Stem Cell Technologies & Application Market Forecast
12.11.1 Favourable Government Policies
12.12 China Stem Cell Technologies & Application Market Forecast
12.12.1 Perspective of China for Cell and Gene Therapies (CGT)
12.13 India Stem Cell Technologies & Application Market Forecast
12.13.1 Increasing Research and Development Activities
12.14 South Korea Stem Cell Technologies & Application Market Forecast
12.14.1 HK inno.N (South Korea) and GC Cell (South Kores) Signed a Joint Research and Development Contract for Creating New Cell Therapies
12.15 Australia Stem Cell Technologies & Application Market Forecast
12.15.1 Rising Number of Companies Entering Stem Cell Technologies and Application Market
12.16 Rest of Asia-Pacific Stem Cell Technologies & Application Market Forecast
12.16.1 Favourable Government Support

13 Latin America Stem Cell Technologies and Applications Market Analysis
13.1 Key Findings
13.2 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
13.3 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
13.4 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
13.5 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
13.6 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
13.7 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
13.8 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
13.9 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
13.10 Brazil Stem Cell Technologies & Application Market Forecast
13.11 Mexico Stem Cell Technologies & Application Market Forecast
13.12 Rest of LATAM Stem Cell Technologies & Application Market Forecast

14 Middle-East & Africa Stem Cell Technologies and Applications Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Stem Cell Technologies and Applications Market Attractiveness Index
14.3 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
14.4 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
14.5 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
14.6 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
14.7 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
14.8 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
14.9 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
14.10 UAE Stem Cell Technologies & Application Market Forecast
14.11 South Africa Stem Cell Technologies & Application Market Forecast
14.12 Turkey Stem Cell Technologies & Application Market Forecast
14.13 Rest of MEA Stem Cell Technologies & Application Market Forecast

15 Competitive Landscape
15.1 Company Share Analysis
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Approval
15.5 Key Business Strategy Analysis- Collaboration
15.6 Key Business Strategy Analysis- Contract
15.7 Key Business Strategy Analysis- Expansion
15.8 Key Business Strategy Analysis- Investment
15.9 Key Business Strategy Analysis- Joint Venture
15.10 Key Business Strategy Analysis- Merger
15.11 Key Business Strategy Analysis- New Product Launch
15.12 Key Business Strategy Analysis- Partnership

16 Company Profiles
16.1 Pipeline Analysis
16.1 Athersys, Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Financial Analysis
16.1.4 Product Benchmarking
16.1.5 Strategic Outlook
16.2 Mesoblast Limited
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Cellular Biomedicine Group, Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Cynata Therapeutics Limited
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Plus Therapeutics, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.4 Product Benchmarking
16.5.5 Strategic Outlook
16.6 Biorestorative Therapies, Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Pluristem Therapeutics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Cellaïon SA
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 Sangamo Therapeutics, Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.9.5 Strategic Outlook
16.10 StemCell Technologies Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Vericel Corporation
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 BrainStorm Cell Limited.
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.4 Product Benchmarking
16.12.5 Strategic Outlook
16.13 Gamida Cell Ltd.
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 ViaCyte, Inc.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.4 Product Benchmarking
16.14.5 Strategic Outlook
16.15 Kangstem Biotech Co., Ltd.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

List of Tables
Table 1 Global Stem Cell Technologies and Applications Market Snapshot, 2022 & 2032 (US$Million, CAGR %)
Table 2 Global Stem Cell Banks and Region
Table 3 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 4 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 5 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 6 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 7 Global Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 8 Global Allogeneic Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 9 Global Allogeneic Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 10 Global Autologous Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 11 Global Autologous Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 12 Global Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 13 Global Adipose tissue-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 14 Global Adipose tissue-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 15 Global Bone marrow-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 16 Global Bone marrow-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 17 Global Placental/umbilical cord-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 18 Global Placental/umbilical cord-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 19 Global Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 20 Global Adult Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 21 Global Adult Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 22 Global Human Embryonic Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 23 Global Human Embryonic Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Induced Pluripotent Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 25 Global Induced Pluripotent Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 26 Global Very Small Embryonic Like Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 27 Global Very Small Embryonic Like Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 28 Global Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 29 Global Cell Acquisition Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 30 Global Cell Acquisition Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 31 Global Cell Production Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 32 Global Cell Production Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 33 Global Cryopreservation Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 34 Global Cryopreservation Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 35 Global Expansion & Sub-Culture Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 36 Global Expansion & Sub-Culture Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 37 Global Other Technology Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 38 Global Other Technology Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 39 Global Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 40 Global Cancer Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 41 Global Cancer Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 42 Global Cardiovascular Diseases Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 43 Global Cardiovascular Diseases Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 44 Global Neurological Disorders Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 45 Global Neurological Disorders Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 46 Global Inflammatory & Autoimmune Diseases Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 47 Global Inflammatory & Autoimmune Diseases Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 48 Global Musculoskeletal Disorders Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 49 Global Musculoskeletal Disorders Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 50 Global Other Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 51 Global Other Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 52 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 53 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 54 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 55 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 56 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 57 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 58 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 59 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 60 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 61 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 62 North America Stem Cell Technologies & Applications Market, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 63 North America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 64 North America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 65 North America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 66 North America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 67 North America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 68 North America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 69 US Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 70 Canada Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 71 Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 72 Europe Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 73 Europe Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 74 Europe Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 75 Europe Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 76 Europe Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 77 Europe Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 78 Germany Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 79 UK Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 80 France Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 81 Italy Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 82 Spain Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 83 Rest of Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 84 Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 85 Asia-Pacific Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 86 Asia-Pacific Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 87 Asia-Pacific Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 88 Asia-Pacific Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 89 Asia-Pacific Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 90 Asia-Pacific Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 91 Japan Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 92 China Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 93 India Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 94 South Korea Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 95 Australia Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 96 Rest of Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 97 Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 98 Latin America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 99 Latin America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 100 Latin America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 101 Latin America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 104 Brazil Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 105 Mexico Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 106 Rest of Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 107 Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 108 Middle East & Africa Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 109 Middle East & Africa Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 110 Middle East & Africa Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 111 Middle East & Africa Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 112 Middle East & Africa Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 113 Middle East & Africa Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 114 UAE Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 115 South Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 116 Turkey Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 117 Rest of Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 118 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 119 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 120 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 121 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 122 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 123 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 124 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 125 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 126 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 127 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 128 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 129 Athersys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Athersys, Inc.: Product Benchmarking
Table 131 Athersys, Inc.: Strategic Outlook
Table 132 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Bristol-Myers Squibb Company: Product Benchmarking
Table 134 Cellular Biomedicine Group, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Cellular Biomedicine Group, Inc. : Product Benchmarking
Table 136 Cellular Biomedicine Group, Inc. : Strategic Outlook
Table 137 Cynata Therapeutics Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Cynata Therapeutics Limited: Product Benchmarking
Table 139 Cynata Therapeutics Limited: Strategic Outlook
Table 140 Plus Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 Plus Therapeutics, Inc.: Product Benchmarking
Table 142 Plus Therapeutics, Inc.: Strategic Outlook
Table 143 BioRestorative Therapies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 BioRestorative Therapies, Inc.: Product Benchmarking
Table 145 BioRestorative Therapies, Inc.: Strategic Outlook
Table 146 Pluristem Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Pluristem Therapeutics Inc.: Product Benchmarking
Table 148 Pluristem Therapeutics Inc.: Strategic Outlook
Table 149 Cellaïon SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Cellaïon SA: Product Benchmarking
Table 151 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 152 Sangamo Therapeutics, Inc.: Product Benchmarking
Table 153 Sangamo Therapeutics, Inc.: Strategic Outlook
Table 154 StemCell Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 155 StemCell Technologies Inc.: Product Benchmarking
Table 156 StemCell Technologies Inc.: Strategic Outlook
Table 157 Vericel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Vericel Corporation: Product Benchmarking
Table 159 Vericel Corporation: Strategic Outlook
Table 160 BrainStorm Cell Limited. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 BrainStorm Cell Limited. : Product Benchmarking
Table 162 BrainStorm Cell Limited. : Strategic Outlook
Table 163 Gamida Cell Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 164 Gamida Cell Ltd.: Product Benchmarking
Table 165 Gamida Cell Ltd.: Strategic Outlook
Table 166 ViaCyte, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 167 ViaCyte, Inc.: Product Benchmarking
Table 168 Kangstem Biotech Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Kangstem Biotech Co., Ltd.: Product Benchmarking
Table 170 Kangstem Biotech Co., Ltd.: Strategic Outlook

List of Figures
Figure 1 Global Stem Cell Technologies and Applications Market Segmentation
Figure 2 Global Stem Cell Technologies and Applications Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 4 Global Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 5 Global Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 6 Global Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 7 Global Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 8 Global Stem Cell Technologies and Applications Market: Market Dynamics
Figure 9 Global COVID Impact Analysis: Stem Cell Technologies and Applications Market Recovery Scenarios 2022-2032 (US$ Mn, CAGR (%))
Figure 10 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “V” Shaped Recovery
Figure 11 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “U” Shaped Recovery
Figure 12 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “W” Shaped Recovery
Figure 13 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “L” Shaped Recovery
Figure 14 Global Stem Cell Technologies and Applications Market: Porter’s Five Forces Analysis
Figure 15 Global Stem Cell Technologies and Applications Market: PESTLE Analysis
Figure 16 Global Stem Cell Technologies and Applications Market Forecast by Type 2022-2032 (Revenue, CAGR%)
Figure 17 Global Stem Cell Technologies and Applications Market Share Forecast by Type, 2022, 2032 (%)
Figure 18 Global Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 19 Global Allogeneic Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn)
Figure 20 Global Allogeneic Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn)
Figure 21 Global Autologous Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn)
Figure 22 Global Autologous Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn)
Figure 23 Global Stem Cell Technologies and Applications Market Forecast by Cell Source 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 24 Global Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022, 2032 (%)
Figure 25 Global Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 26 Global Adipose tissue-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 27 Global Adipose tissue-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 28 Global Bone marrow-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 29 Global Bone marrow-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 30 Global Placental/umbilical cord-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 31 Global Placental/umbilical cord-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 32 Global Stem Cell Technologies and Applications Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 33 Global Stem Cell Technologies and Applications Market Share Forecast by Product, 2022, 2032 (%)
Figure 34 Global Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 35 Global Adult Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 36 Global Adult Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 37 Global Human Embryonic Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 38 Global Human Embryonic Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 39 Global Induced Pluripotent Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 40 Global Induced Pluripotent Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 41 Global Very Small Embryonic Like Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 42 Global Very Small Embryonic Like Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 43 Global Stem Cell Technologies and Applications Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 44 Global Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022, 2032 (%)
Figure 45 Global Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 46 Global Cell Acquisition Market Forecast, 2022-2032 (US$ Mn)
Figure 47 Global Cell Acquisition Market by Region, 2022-2032 (US$ Mn)
Figure 48 Global Cell Production Market Forecast, 2022-2032 (US$ Mn)
Figure 49 Global Cell Production Market by Region, 2022-2032 (US$ Mn)
Figure 50 Global Cryopreservation Market Forecast, 2022-2032 (US$ Mn)
Figure 51 Global Cryopreservation Market by Region, 2022-2032 (US$ Mn)
Figure 52 Global Expansion & Sub-Culture Market Forecast, 2022-2032 (US$ Mn)
Figure 53 Global Expansion & Sub-Culture Market by Region, 2022-2032 (US$ Mn)
Figure 54 Global Other Technology Market Forecast, 2022-2032 (US$ Mn)
Figure 55 Global Other Technology Market by Region, 2022-2032 (US$ Mn)
Figure 56 Global Stem Cell Technologies and Applications Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 57 Global Stem Cell Technologies and Applications Market Share Forecast by Application, 2022, 2032 (%)
Figure 58 Global Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 59 Global Cancer Market Forecast, 2022-2032 (US$ Mn)
Figure 60 Global Cancer Market by Region, 2022-2032 (US$ Mn)
Figure 61 Global Cardiovascular Diseases Market Forecast, 2022-2032 (US$ Mn)
Figure 62 Global Cardiovascular Diseases Market by Region, 2022-2032 (US$ Mn)
Figure 63 Global Neurological Disorders Market Forecast, 2022-2032 (US$ Mn)
Figure 64 Global Neurological Disorders Market by Region, 2022-2032 (US$ Mn)
Figure 65 Global Inflammatory & Autoimmune Diseases Market Forecast, 2022-2032 (US$ Mn)
Figure 66 Global Inflammatory & Autoimmune Diseases Market by Region, 2022-2032 (US$ Mn)
Figure 67 Global Musculoskeletal Disorders Market Forecast, 2022-2032 (US$ Mn)
Figure 68 Global Musculoskeletal Disorders Market by Region, 2022-2032 (US$ Mn)
Figure 69 Global Other Applications Market Forecast, 2022-2032 (US$ Mn)
Figure 70 Global Other Applications Market by Region, 2022-2032 (US$ Mn)
Figure 71 Global Stem Cell Technologies and Applications Market Forecast by Region 2022-2032: Market Attractiveness Index
Figure 72 Global Stem Cell Technologies and Applications Market Share Forecast by Application, 2022, 2032 (%)
Figure 73 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn)
Figure 74 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 75 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 76 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 77 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 78 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%))
Figure 79 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 80 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 81 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 82 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 83 North America Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 84 North America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 85 North America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 86 North America Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 87 North America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 88 North America Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 89 North America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 90 North America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 91 North America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 92 North America Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 93 North America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 94 North America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 95 North America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 96 North America Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 97 US Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 98 Canada Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 99 Europe Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 100 Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 101 Europe Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 102 Europe Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 103 Europe Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 104 Europe Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 105 Europe Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 106 Europe Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 107 Europe Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 108 Europe Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 109 Europe Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 110 Europe Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 111 Europe Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 112 Europe Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 113 Germany Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 114 UK Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 115 France Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 116 Italy Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 117 Spain Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 118 Rest of Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 119 Asia-Pacific Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 120 Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 121 Asia-Pacific Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 122 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 123 Asia-Pacific Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 124 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 125 Asia-Pacific Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 126 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 127 Asia-Pacific Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 128 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 129 Asia-Pacific Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 130 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 131 Asia-Pacific Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 132 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 133 Japan Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 134 China Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 135 India Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 136 South Korea Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 137 Australia Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 138 Rest of Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 139 Latin America Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 140 Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 141 Latin America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 142 Latin America Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 143 Latin America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 144 Latin America Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 145 Latin America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 146 Latin America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 147 Latin America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 148 Latin America Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 149 Latin America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 150 Latin America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 151 Latin America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 152 Latin America Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 153 Brazil Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 154 Mexico Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 155 Rest of Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 156 Middle East & Africa Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 157 Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 158 Middle East & Africa Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 159 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 160 Middle East & Africa Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 161 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 162 Middle East & Africa Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 163 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 164 Middle East & Africa Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 165 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 166 Middle East & Africa Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 167 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 168 Middle East & Africa Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 169 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 170 UAE Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 171 South Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 172 Turkey Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 173 Rest of Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 174 Global Stem Cell Technologies and Applications Market: Company Share Analysis, 2021
Figure 175 Athersys, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 176 Athersys, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 177 Athersys, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 178 Athersys, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 179 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 180 Bristol-Myers Squibb Company: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 181 Bristol-Myers Squibb Company: R&D, 2017-2021 (US$ million, AGR (%))
Figure 182 Bristol-Myers Squibb Company: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 183 Cellular Biomedicine Group, Inc. : Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 184 Cellular Biomedicine Group, Inc. : Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 185 Cellular Biomedicine Group, Inc. : R&D, 2017-2021 (US$ million, AGR (%))
Figure 186 Cellular Biomedicine Group, Inc. : EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 187 Cynata Therapeutics Limited: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 188 Cynata Therapeutics Limited: R&D, 2017-2021 (US$ million, AGR (%))
Figure 189 Cynata Therapeutics Limited: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 190 Plus Therapeutics, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 191 Plus Therapeutics, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 192 Plus Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 193 Plus Therapeutics, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 194 BioRestorative Therapies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 195 BioRestorative Therapies, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 196 BioRestorative Therapies, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 197 BioRestorative Therapies, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 198 Pluristem Therapeutics Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 199 Pluristem Therapeutics Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 200 Pluristem Therapeutics Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 201 Pluristem Therapeutics Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 202 Sangamo Therapeutics, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 203 Sangamo Therapeutics, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 204 Sangamo Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 205 Sangamo Therapeutics, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 206 StemCell Technologies Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 207 StemCell Technologies Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 208 StemCell Technologies Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 209 StemCell Technologies Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 210 Vericel Corporation: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 211 Vericel Corporation: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 212 Vericel Corporation: R&D, 2017-2021 (US$ million, AGR (%))
Figure 213 Vericel Corporation: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 214 BrainStorm Cell Limited. : R&D, 2017-2021 (US$ million, AGR (%))
Figure 215 BrainStorm Cell Limited. : EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 216 Gamida Cell Ltd.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 217 Gamida Cell Ltd.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 218 Kangstem Biotech Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 219 Kangstem Biotech Co., Ltd.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 220 Kangstem Biotech Co., Ltd.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 221 Kangstem Biotech Co., Ltd.: EBITDA, 2017-2021 (US$ million, AGR (%))

この商品のレポートナンバー

0000033723

TOP